An update on inhibitors targeting RNA-dependent RNA polymerase for COVID-19 treatment: Promises and challenges

Xiaoying Xu1, Yuheng Chen2, Xinyu Lu3

  • 1School of Basic Medical Sciences, Zhejiang Chinese Medical University, Hangzhou 310053, China.

Biochemical Pharmacology
|October 9, 2022
PubMed

Insights

This review explores RNA-dependent RNA polymerase (RdRp) inhibitors as potential COVID-19 therapeutics. It analyzes inhibitor interactions and effectiveness, proposing strategies for developing new antiviral drugs against SARS-CoV-2 variants.

Area of Science:

  • Virology
  • Drug Discovery
  • Structural Biology

Background:

  • The COVID-19 pandemic, caused by SARS-CoV-2, necessitates urgent development of effective therapeutic drugs.
  • Highly transmissible SARS-CoV-2 variants continue to drive global infection waves.
  • RNA-dependent RNA polymerase (RdRp) is a conserved and essential viral enzyme, making it a prime target for antiviral therapies.

Purpose of the Study:

  • To review recent advancements in the study of RNA-dependent RNA polymerase (RdRp) inhibitors.
  • To analyze the structural interactions between RdRp inhibitors and the enzyme complex.
  • To evaluate the effectiveness of current RdRp inhibitors and propose future development strategies.

Main Methods:

  • Literature review of studies on RdRp inhibitors.
  • Analysis of structural data detailing inhibitor-enzyme interactions.
  • Assessment of inhibitor efficacy against SARS-CoV-2.

Main Results:

  • RdRp is a highly conserved enzyme across coronaviruses and a promising target for antiviral drug development.
  • Structural analysis reveals key interactions between inhibitors and the RdRp enzyme complex.
  • Current inhibitors show varying degrees of effectiveness, highlighting the need for improved strategies.

Conclusions:

  • RdRp inhibitors represent a critical avenue for combating COVID-19.
  • Understanding structural interactions is key to designing potent and specific inhibitors.
  • Further research into novel strategies is essential for developing next-generation SARS-CoV-2 therapeutics.

Related Concept Videos

RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.3K
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.9K
Types of RNA01:23

Types of RNA

Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
64.4K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.2K
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
10.0K
Viruses with RNA Genomes01:29

Viruses with RNA Genomes

RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
94